ArticleAAPS open2023

Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections.

David NeedhamPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.